Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cells

BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201515:378

https://doi.org/10.1186/s12906-015-0909-8

Received: 22 July 2015

Accepted: 11 October 2015

Published: 21 October 2015

Abstract

Background

Chronic kidney disease poses a serious health problem worldwide with increasing prevalence and lack of effective treatment. This study aimed to investigate the mechanism of icariin in alleviating chronic renal failure induced by 5/6 nephrectomy in rats.

Methods

The chronic renal failure model was established by a two-phased 5/6 nephrectomy procedure. The model rats were given daily doses of water or icariin for 8 weeks. The kidney morphology was checked by HE staining. The levels of blood urea nitrogen, serum creatinine, and serum uric acid were measured by colometric methods. The expression of specified genes was analyzed by quantitative real-time PCR and immunohistochemical staining. The number of renal stem/progenitor cells was analyzed by CD133 and CD24 immunohistochemical staining.

Results

Icariin protected against CDK-caused damages to kidney histology and improved renal function, significantly reduced levels of BUN, creatinine, and uric acid. Icariin inhibited the expression level of TGF-β1 whereas upregulated HGF, BMP-7, WT-1, and Pax2 expression. Moreover, ccariin significantly increased the expression of CD24, CD133, Osr1, and Nanog in remnant kidney and the numbers of CD133+/CD24+ renal stem/progenitor cells.

Conclusions

These data demonstrated that icariin effectively alleviated 5/6 nephrectomy induced chronic renal failure through increasing renal stem/progenitor cells.

Keywords

Chronic kidney failure Icariin Renal function Renal stem cells

Background

The kidneys function as the cleansing and recycling apparatus of the body removing waste products of metabolism and water soluble wastes from blood, excreting urea and ammonium, reabsorbing water, glucose, and amino acids, by which they serve homeostatic functions such as the regulation of electrolytes, maintenance of acid-base and salt-water balances, and regulation of blood pressure. Besides, the kidneys also serve as an endocrine organ producing hormones calcitriol and erythropoietin among others, and the enzyme rennin. Chronic kidney disease (CKD) is a collective term for any process causing the pathological changes to the structure of kidney which may consequently reduce renal function and disturbs the physiological homeostasis, a process collectively termed [1, 2]. There is a continuous increase of the prevalence of CDK worldwide [35], which results in dramatic increasing incidences of end-stage renal disease (ESRD) [2] that require renal replacement therapy or undergoing dialysis due to lack of kidney donor.

Stem cell research and regenerative medicine provide a hope for treating CKD and even ERSD. However, it is extremely challenging to reconstruct human kidney because of its complicated anatomical structure and no regenerating zone of renal tissue to form new nephrons [6]. A variety insults could injure different renal cells including podocytes, tubular epithelial cells, mesangial cells, and endothelial cells. While the sublethal injuries damage renal function to different degrees, they could also activate the regenerating process for repairing the injuried kidney tissues [7]. It has been shown that renal dysfunction could be reversed by stimulating the angiogenic signaling and increasing renal microvasculature density [8, 9]. Many animal studies have shown that renal cells could be modulated genetically or pharmacologically to promote kidney regeneration [3, 10].

Icariin, a flavonoid from plants of genus Epimedium, has been shown therapeutic potential for neurodegeneration, memory and depressive disorders, chronic inflammation, cardiovascular diseases, diabetes, osteoporosis, cancer, reproductive disorders, and immune dysfunction [11, 12]. Icariin promoted self-renewal of mouse neural stem cells in vitro [13], the activation of quiescent neural stem cells of aged rats in vivo [14], and the differentiation of mesenchymal or stem cells into cardiomyocytes, osteoblasts, and endothelial cells [1518]. The aim of this study was to investigate whether icariin could modulate renal stem cell population to repair kidney injury and alleviate chronic renal failure in a rat 5/6 nephrectomy model.

Methods

Animals

Eighty male Sprague Dawley rats (SPF class, 150 ± 10 g) were purchased from Shanghai Laboratory Animal Research Center (Shanghai, China) and kept in the laboratory animal center of Shanghai University of Traditional Chinese Medicine. The animals were given food and water ad libitho. All animal procedures were adhered to the Declaration of Helsinki and approved by the IACUC of Shanghai University of Traditional Chinese Medicine (SCXK (Shanghai) 2008-0016).

The renal failure rat model was established by a two-phased procedure of 5/6 nephrectomy. Rats were given 3 % sodium pentobarbital at 2 ml/kg dose intraperitoneally. After anesthesia, rats were put into left lateral position, shaved, disinfected with 75 % ethanol. Locating the kidney under rib ridge and cutting a about 2 cm opening on skin, then cut the muscles; use tweezers to pull up the kidney out of surrounding fat, peel off renal cell membrane from the lower end (to avoid injury to adrenal gland); cut off about 5/6 renal tissue near both ends but keep parts around the renal hilum to avoid disruption of blood supply; wrap remaining kidney twice with a thick line and stretch 10 min with hemostat. When there was no further bleeding, the opening was sutured layer by layer and wiped clean with cotton swab. A week later the right renal hilum was ligated with thick lines to make kidney necrosis. The sham group rats were undergone the same procedure but without cutting any kidney tissue. The establishment of renal failure model was confirmed by serum creatinine level 2 weeks later.

Treatments

The rats were randomly put into sham, CKD model, and groups with 20 rats in each group. Sham and control rats were given water 3 ml/day, icariin group were given icariin (40 mg/kg/d, CAS:489-32-7, Shanghai Winherb Medical Technology, Shanghai, China) in 3 ml/day by gavage for 8 weeks. Then the rats were sacrificed by approved standard procedure, blood was collected via celiac artery, and kidney was divided into two sections longitudinally, one part for RNA work and the other for hematoxylin and eosin (H&E) and immunohistochemical staining.

Kidney function assays

Serum urea nitrogen was measured by diacetyloxime colorimetric method, serum creatinine by picric acid method, and uric acid by colorimetric method.

Kidney histology

Kidney tissue was fixed in 10 % formalin and sectioned followed by Hematoxylin and Eosin (H&E) staining and light microscopy (Olympus IX70, Olympus, Shinjuku, Tokyo, Japan) observation.

Reverse transcription and quantitative polymerase chain reaction (qPCR)

Total mRNA was extracted from kidney tissue samples using Trizol (Life Technologies, Shanghai, China) method. The first strand cDNA was synthesized with 2 μg total RNA using a reverse transcriptase kit from Biotnt (Shanghai, China) according to manufacturer’s protocol. Quantitative PCR was performed in 20 μl total reaction mix using Fast SYBR® Green Master Mix (Life Technologies) on a ABI 7500 fast (Applied Biosystems, Foster City, CA) with 95 °C for 5 min followed by 40 cycles of 95 °C 5 s and 60 °C 30 s. The sequences of specific primers were listed in Table 1. The relative gene expression levels were calculated by 2-ΔΔCt method with β-actin as the internal control.
Table 1

Sequences of qPCR primers used in this study

Gene

Primer sequences

Amplicon (bp)

TGF-β1

GAAGGACCTGGGTTGGAAG

136

CGGGTTGTGTTGGTTGTAG

HGF

CCTATTTCCCGTTGTGAAG

138

ACTAACCATCCACCCTACT

BMP-7

ACTACTGTGAGGGAGAGTG

97

TCTGGGTTGATGAAGTGAA

Wt1

AAAAGTGGCTCACAGTGTC

139

ATGGAACAACCGCTCTAAT

Pax-2

CTGGGCAGGTACTACGAGA

190

CGCTGGGAACTGTATCATT

CD24

CCAGCCACCCCTGAGTAAATC

90

GAACTTAGTACCCGTGGTGAGTGA

CD133

ACGGAAGTCAGCTCCCATCA

76

GGCTCTCCAGATCGGTTCTG

Osr1

TTCTAAAGTGCCAGGTGCGG

79

GACGTGTGGAAACCAGGGAA

Nanog

TGCTCCGCTCCATAACTTCG

100

AGTGGCTTCCAAATTCGCCT

β-actin

CTCACTGTCCACCTTCCAGC

121

AAGGGTGTAAAACGCAGCTCA

Immunohistochemical (IHC) staining

To detect the protein levels of TGF-β1, HGF, and BMP-7 and CD133 and CD24 positive cells in kidney tissue, IHC staining with specific antibodies was performed. The sections were deparaffinized and rehydrated, quenched with 3 % H2O2 for 10 min, immersed in citrate buffer and heated in microwave at mid power for 3 min, cooled down to room temperature and repeated heating another time before being washed twice in PBS at 5 min each and blocked with normal rabbit serum for 30 min at 37 °C, followed by incubating with specified 1st antibodies at 4 °C over night and proper 2nd antibodies at 37 °C for 30 min. The antibodies used were TGF-β1, HGF, and BMP-7 from Abcam (Cambridge, MA), CD24 from Santa Cruz (Santa Cruz, CA), and CD133 from Boster (Wuhan, China). The secondary antibodies were purchased from Jackson ImmunoResearch Lab (West Grove, PA). The sections were washed 3 times with PBS before color development with a DAB kit (SA1020, Boster, Wuhan, China) and counterstained with hematoxylin, washed, dehydrated, cleared, and mounted. The slides were observed and photographed on a Olympus IX70 (Olympus, Shinjuku, Tokyo, Japan). The immunohistochemical staining results were semi quantitatively analyzed by combining the score of staining intensity and the score of percentage of positive cells. The positive staining ranged from pale yellow to brown. Staining intensity was scored as 0 for now color, 1 for pale yellow, 2 for yellow, 3 for brown. The percentage of positive cells was scored as 0 for 0 to 5 %, 1 for 6 to 25 %, 2 for 26 to 50 %, 3 for 51 to 75 %, and 4 for >75 %. The final score was the product of the scores of staining intensity and the score of percentage of positive cells. Scores of 5 random fields (x400) were obtained from each slide.

Statistical analyses

Data was expressed as mean ± standard deviation. Statistical analysis was performed using SPSS17.0 software package (IBM, Armonk, NY). The difference between the averages of groups was analyzed by one way ANOVA (analysis of variation), the homogeneity of variance between groups was determined by Levene’s test and set 0.10 significance level; multiple comparisons between two groups were performed by SNK test if variances were assumed equal and by Tamhane’s T2 test if variances were not assumed equal. A p value less than 0.05 was considered statistically significant.

Results

Icariin (Icariin) alleviated the pathological changes of chronic kidney disease

Hematoxylin and Eosin (H&E) staining showed that kidney morphology was well preserved in sham operated rats (Fig. 1a). It showed normal glomerular structure, capillaries were not narrowed or occluded, capillary basement membrane lined well without enlargement; Bowman’s capsule space was clear without expansion, glomerular capsule and glomerulus were separated; tubule structure was normal without protein cast or interstitial inflammatory cell infiltration.
Fig. 1

Icariin alleviated chronic renal failure induced morphological damages to rat kidney. The kidney histology of rats underwent sham operation, 5/6 nephrectomy (CKD model), and CKD treated with icariin was observed by Hematoxylin and Eosin staining. The representative pictures were shown. Yellow arrows indicated tubular lesion and tubules lacking obvious brush border; black arrows indicated tubular necrosis and inflammatory cell infiltration; and green arrows indicated glomerular damages

Massive histological changes were observed in the kidneys of rats undergone 5/6 nephrectomy (model group) (Fig. 1b). The glomerular structure was disorganized with severe mesangial expansion, significant basement membrane thickening, and capillary compression or occlusion. Glomeruli had diffuse glomerular sclerosis with increased mesangial matrix area, reduced number of cells, glomerular fibrosis, and severe adhesions to Bowman’s capsules. A considerable amount of protein casts were observed in renal tubule lumen, which was significantly expanded with fibrosis and narrowing in some tubules. There was renal interstitial fibrosis and edema with large number of infiltrated inflammatory cells. Some small arteries showed intimal thickening, hyaline degeneration, and stenosis.

Compared to the model group, rats undergone 5/6 nephrectomy and received icariin treatment (Fig. 1c) had significantly reduced glomerular lesions with mild mesangial hyperplasia, mild basement membrane thickening, and unobvious glomerular sclerosis. Bowman’s capsules had normal morphology without significant adhesions with glomeruli. The structure of renal tubules was nearly normal with mild renal tubular epithelial cell swelling, lumen expansion, mild stenosis without apparent protein casts, and few interstitial inflammatory cell infiltration.

Icariin protected renal function against chronic kidney disease

The blood urea nitrogen (BUN) level was increased from 6.084 ± 0.574 mmol/L (95 % CI: 5.371 – 6.797 mmol/L) in sham rats to 17.671 ± 2.820 mmol/L (95 % CI: 15.653 – 19.688 mmol/L) in CKD model rats (p < 0.01). This increased level of BUN in CKD rats was significantly reduced by icariin (Fig. 2a). The levels of serum creatinine (Fig. 2b) and uric acid (Fig. 2c) had similar changes as BUN in CKD rats among different treatment groups.
Fig. 2

Icariin protected renal function against chronic kidney disease. The levels of blood urea nitrogen (a), serum creatinine (b), and serum uric acid (c) were measured by specific colometric methods. BNU, blood urea nitrogen; CR, serum creatinine; UA, uric acid. Data was expressed as mean ± standard deviation (n = 15). *, p < 0.01 compared to sham group; #, p < 0.01 compared to CKD model group

Icariin promoted the expression of genes related to stem cell proliferation

Chronic kidney disease and icariin treatment each triggered changes of the expression of genes involved in stem cell/renal progenitor cell proliferation (Figs. 3 and 4). The renal mRNA levels of TGF-β1 (Fig. 3a), HGF (Fig. 3b), and WT-1 (Fig. 3d) were significantly higher whereas renal mRNA levels of BMP-7 (Fig. 3c) and Pax-2 (Fig. 3e) were significantly lower in CKD rats compared with those of healthy rats. Icariin drastically reduced the mRNA level of TGF-β1 (Fig. 3a) while increased the levels of HGF (Fig. 3b), BMP-7 (Fig. 3c), WT-1 (Fig. 3d), and Pax-2 (Fig. 3e) in CKD rats.
Fig. 3

Icariin modulated kidney gene expression profile to favor injury repair. The mRNA levels of TGF-β1 (a), HGF (b), BMP-7 (c), WT-1 (d), and Pax-2 (e) were analyzed by quantitative real-time PCR. Data was expressed as mean ± standard deviation (n = 15). *, p < 0.01 compared to sham group; #, p < 0.01 compared to CKD model group

Fig. 4

Icariin increased the protein levels of HGF and BMP-7 while reduced TGF-β1 level. The protein levels of TGF-β1 (a), HGF (b), and BMP-7 (c) in rat kidney were assayed by immunohistochemical staining with specific antibodies. Representative pictures and the quantitative summaries were given. *, p < 0.01 compared to sham group; #, p < 0.01 compared to CKD model group

Consistently, the protein level of TGF-β1 was strongly elevated by injury-induced CKD, which was markedly inhibited by icariin and to a lesser extent by losartan (Fig. 4a). The HGF protein level in the residual kidney of CKD rats was significantly increased by icariin (Fig. 4b) while BMP-7 protein level in CKD rats was only recovered back to about the normal rats by icariin from more than 50 % decrease in CKD rats (Fig. 4c).

Icariin promoted the proliferation of renal stem/progenitor cells

The mRNA levels of markers of renal stem cell CD133 (Fig. 5a), CD24 (Fig. 5b), and Osr1 (Fig. 5c) and pluropotency (Nanog, Fig. 5d) were increased in the remnant kidney of 5/6 nephrectomy CKD rats and further increased 3-5 folds by icariin treatment (Fig. 5).
Fig. 5

Icariin up-regulated the expression of renal stem cell markers. The mRNA levels of CD133 (a), CD24 (b), Osr1 (c), and Nanog (d) in the remnant kidney were analyzed by quantitative real-time PCR. Data was expressed as mean ± standard deviation (n = 15). *, p < 0.01 compared to sham group; #, p < 0.01 compared to CKD model group

The number of CD133+ renal cells decreased about 65 % in CKD rats compared to healthy rats and icariin treatment resulted in about 5 fold increase of CD133+ cells in the kidney of CKD rats (Fig. 6a). The numbers of CD24+ cells had similar changes among healthy rats, CKD rats, and icariin or losartan- treated rats (Fig. 6b). Meanwhile, the numbers of renal stem/progenitor cells were correlated with kidney functions (Table 2), especially, CD133+ cell number showed tight negative correlation with BUN and creatinine levels.
Fig. 6

Icariin increased the numbers of CD133+ and CD24+ renal stem/progenitor cells. The numbers of CD133+ (a) and CD24+ (b) cells in rat kidney were semi-quantitatively measured by immunohistochemical staining with specific antibodies against CD133 and CD24. Representative pictures and the quantitative summaries were given. *, p < 0.01 compared to sham group; #, p < 0.01 compared to CKD model group

Table 2

Correlation between renal function and the number of renal stem/progenitor cells

  

BUN

Cr

CD133

CD24

BUN

Pearson Correlation

1

0.966**

−0.979**

−0.912*

Sig. (1-tailed)

 

0.004

0.002

0.015

Cr

Pearson Correlation

0.966**

1

−0.946**

−0.799

Sig. (1-tailed)

0.004

 

0.008

0.053

CD133

Pearson Correlation

−0.979**

−0.946**

1

0.935**

Sig. (1-tailed)

0.002

0.008

 

0.01

CD24

Pearson Correlation

−0.912*

−0.799

0.935**

1

Sig. (1-tailed)

0.015

0.053

0.01

 

BUN blood urea nitrogen; Cr serum creatinine

*, p < 0.05; **, p < 0.01

Discussions

Injury-induced chronic kidney disease caused profound histological changes including glomeruli damages, tubular necrosis, and infiltration of inflammatory cells in rat kidneys, which was accompanied with loss of renal functions indicated by the increase of BUN, creatinine, and uric acid levels. Icariin alleviated all such pathological changes, e. g. seldom tubular damages and much less immune cell infiltration, complete glomeruli structure, and nearly normal levels of BUN, creatinine, and uric acid in CKD rats received icariin. Furthermore, icariin significantly increased the numbers of CD133+ and CD24+ renal stem/progenitor cells in injury-induced CKD rats. Icariin activated the expression of genes promoting renal stem/progenitor cells proliferation and inhibited the expression of fibrosis-promoter TGF-β1.

Renal regeneration is at the center of treating chronic kidney failure and other kidney diseases [10, 19, 20]. As icariin was renal protective by changing cell cycle distribution of renal cells [21] and was shown to promote the maintenance, activation, and differentiation of many types of stem cells [1318], we postulated that the action of icariin in improving renal function would involve the activation of pathways promoting the proliferation and/or homing of renal stem/progenitor cells (Fig. 7). Among the factors involved in kidney development and kidney injury recovery, hepatocyte growth factor (HGF) and bone morphogenetic protein-7 (BMP-7) were analyzed and both found significantly increased by icariin in CKD rat kidney tissues. HGF/HGF receptor c-met signaling conferred renal protective effect by preventing apoptosis, reducing inflammation, and inhibiting TGF-β-induced fibrosis [22, 23]. BMP-7 promoted kidney regeneration by inhibiting the precocious differentiation of the kidney progenitor cells and antagonizing the TGF-β in inducing fibrosis [24, 25]. Moreover, icariin significantly up-regulated the expression of genes important for the proliferation and differentiation of renal stem/progenitor cells (Osr1, NMP-7, Pax2 and WT-1), which led to the increase of renal CD133+ and/or CD24+ stem/progenitor cells. Renal CD133+CD24+PDX- cells were shown to be the uncommitted stem cells which possessed the potentials of self renewal and differentiation into both podocytes and tubular cells [26, 27]. The elevation of Osr1, Nanog, HGF, BMP-7, WT-1, and Pax2 expression in CKD rat kidney by Icariin was well in correlation with the increased numbers of CD133+ and/or CD24+ stem/progenitor cells while the reduced expression of TGF-β1 leading to the blocking of interstitial fibrosis (Fig. 7).
Fig. 7

Proposed model for the actions of icariin in alleviating CKD. Icariin activates the expression of genes promoting the proliferation, survival, and differentiation of renal stem cells (e. g. HGF, BMP-7, Pax-2, and WT-1) and inhibits genes promoting inflammation and fibrosis (e. g. TGF-β1), which leads to the increase of renal stem/progenitor cells and the repair of kidney injuries

Conclusions

In summary, icariin attenuated the progression of sub-total nephrectomy induced chronic renal failure in rats. Icariin moderated the loss of the integrity of kidney histology and renal function in CKD rats. Those structural and functional benefits of icariin were accompanied by the increased expression of genes promoting the proliferation of renal stem/progenitor cells as well as the increase of the numbers of CD133+ and/or CD24+ renal stem/progenitor cells.

Abbreviations

CKD: 

Chronic kidney disease

ESRD: 

End-stage renal disease

H&E: 

Hematoxylin and Eosin

qPCR: 

Quantitative polymerase chain reaction

IHC: 

Immunohistochemistry

BUN: 

Blood urea nitrogen

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
(2)
Department of nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
(3)
Traditional Chinese Medicine Institute of Kidney Diseases, Shanghai University of Traditional Chinese Medicine
(4)
Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
(5)
Collage of Biology and pharmacy, China Three Gorges University

References

  1. Dziedzic K, Pleniceanu O, Dekel B. Kidney stem cells in development, regeneration and cancer. Semin Cell Dev Biol. 2014;36:57–65.View ArticlePubMedGoogle Scholar
  2. Faa G, Sanna A, Gerosa C, Fanni D, Puddu M, Ottonello G, et al. Renal physiological regenerative medicine to prevent chronic renal failure: Should we start at birth? Clin Chim Acta. 2015;444:156–62.View ArticlePubMedGoogle Scholar
  3. Chou YH, Pan SY, Yang CH, Lin SL. Stem cells and kidney regeneration. J Formos Med Assoc. 2014;113:201–9.View ArticlePubMedGoogle Scholar
  4. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.View ArticlePubMedGoogle Scholar
  5. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9:e84943.PubMed CentralView ArticlePubMedGoogle Scholar
  6. Hopkins C, Li J, Rae F, Little MH. Stem cell options for kidney disease. J Pathol. 2009;217:265e81.View ArticleGoogle Scholar
  7. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2:284e91.View ArticleGoogle Scholar
  8. Chade AR, Kelsen S. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Am J Physiol Renal Physiol. 2012;302:F1342–1350.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Long DA, Norman JT, Fine LG. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol. 2012;8:244–50.View ArticlePubMedGoogle Scholar
  10. Benigni A, Morigi M, Remuzzi G. Kidney regeneration. Lancet. 2010;375:1310–7.View ArticlePubMedGoogle Scholar
  11. Schluesener JK, Schluesener H. Plant polyphenols in the treatment of age-associated diseases: revealing the pleiotropic effects of icariin by network analysis. Mol Nutr Food Res. 2014;58:49–60.View ArticlePubMedGoogle Scholar
  12. Li C, Li Q, Mei Q, Lu T. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii. Life Sci. 2015;126:57–68.View ArticlePubMedGoogle Scholar
  13. Huang JH, Cai WJ, Zhang XM, Shen ZY. Icariin promotes self-renewal of neural stem cells: an involvement of extracellular regulated kinase signaling pathway. Chin J Integr Med. 2014;20:107–15.View ArticlePubMedGoogle Scholar
  14. Wu B, Chen Y, Huang J, Ning Y, Bian Q, Shan Y, et al. Icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats. J Ethnopharmacol. 2012;142:746–53.View ArticlePubMedGoogle Scholar
  15. Zhou L, Huang Y, Zhang Y, Zhao Q, Zheng B, Lou Y, et al. mGluR5 stimulating Homer-PIKE formation initiates icariin induced cardiomyogenesis of mouse embryonic stem cells by activating reactive oxygen species. Exp Cell Res. 2013;319:1505–14.View ArticlePubMedGoogle Scholar
  16. Zhai YK, Guo XY, Ge BF, Zhen P, Ma XN, Zhou J, et al. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG. Bone. 2014;66:189–98.View ArticlePubMedGoogle Scholar
  17. Wu Y, Xia L, Zhou Y, Xu Y, Jiang X. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif. 2015;48:375–84.View ArticlePubMedGoogle Scholar
  18. Tang Y, Jacobi A, Vater C, Zou L, Zou X, Stiehler M. Icariin promotes angiogenic differentiation and prevents oxidative stress-induced autophagy in endothelial progenitor cells. Stem Cells. 2015;33:1863–77.View ArticlePubMedGoogle Scholar
  19. Maeshima A, Nakasatomi M, Nojima Y. Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy. Biomed Res Int. 2014;2014:595493.PubMed CentralPubMedGoogle Scholar
  20. Morigi M, Benigni A. Mesenchymal stem cells and kidney repair. Nephrol Dial Transplant. 2013;28:788–93.View ArticlePubMedGoogle Scholar
  21. Liang SR, Bi JW, Guo ZL, Bai Y, Hu Z. Protective effect of icariin on kidney in 5/6 nephrectomized rats and its mechanism. Genet Mol Res. 2014;13:6466–71.View ArticlePubMedGoogle Scholar
  22. Yazawa K, Isaka Y, Takahara S, Imai E, Ichimaru N, Shi Y, et al. Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Nephrol Dial Transplant. 2014;19:812–6.View ArticleGoogle Scholar
  23. Zhou D, Tan RJ, Lin L, Zhou L, Liu Y. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int. 2013;84:509–20.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Tomita M, Asada M, Asada N, Nakamura J, Oguchi A, Higashi AY, et al. Bmp7 maintains undifferentiated kidney progenitor population and determines nephron numbers at birth. PLoS One. 2013;8:e73554.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Lv S, Liu G, Sun A, Wang J, Cheng J, Wang W, et al. Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7. Diab Vasc Dis Res. 2014;11:251–61.View ArticlePubMedGoogle Scholar
  26. Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009;20:322–32.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Romagnani P, Remuzzi G. CD133+ renal stem cells always co-express CD24 in adult human kidney tissue. Stem Cell Res. 2014;12:828–9.View ArticlePubMedGoogle Scholar

Copyright

© Huang et al. 2015

Advertisement